Assesses adults 19–64 years of age who have schizophrenia and were dispensed and remained on an antipsychotic medication for at least 80% of their treatment period.
Why It Matters
Schizophrenia is a chronic and disabling psychiatric disorder that requires ongoing treatment and monitoring. Symptoms include hallucinations, illogical thinking, memory impairment and incoherent speech.1 Medication nonadherence is common and a major concern in the treatment of schizophrenia. Using antipsychotic medications as prescribed reduces the risk of relapse or hospitalization.2
Results
Adherence to Antipsychotic Medications for Individuals with Schizophrenia Rate
| Year | Medicaid HMO |
|---|---|
| 2018 | 59.8 |
| 2017 | 59.1 |
| 2016 | 59.2 |
| 2015 | 58.0 |
| 2014 | 60.1 |
| 2013 | 60.1 |
References
- American Psychiatric Association. Schizophrenia Fact Sheet.
https://www.psychiatry.org/File%20Library/Psychiatrists/Practice/DSM/APA_DSM-5-Schizophrenia.pdf - Busch, A.B., A.F. Lehman, H. Goldman, & R.G. Frank. 2009. “Changes over time and disparities in schizophrenia treatment quality.” Med Care 47(2), 199–207.